CNE000001733
CNE000001733
GUANGZHOU BAIYUNSHAN PHARMACEUT
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 32.47B EUR | 32.58B EUR | 37.17B EUR |
Enterprise Value | 29B EUR | 38.83B EUR | 43.29B EUR |
Valuation Multiples | |||
Trailing P/E | 12.64x | 13.22x | 9.35x |
Forward P/E | 12.1x | -- | -- |
Price to Sales | 0.42x | 0.42x | 0.46x |
Price to Book | 0.83x | 0.83x | 0.94x |
EV/Revenue | 0.37x | 0.5x | 0.53x |
EV/EBITDA | 8.29x | 11.08x | 8.05x |
Price to FCF (P/FCF) | -- | 38.43x | -- |
EV/FCF | -- | 45.81x | -- |
FCF Yield | -1.48% | 2.6% | -13.26% |